---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-005237"
form_type: "8-K"
ticker: "DRIO"
cik: "0001533998"
company_name: "DarioHealth Corp."
filed_at: "2025-01-22T23:59:59+00:00"
generated_at: "2026-05-27T19:21:51.247086+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# DarioHealth closes $25.6M private placement; targets cash flow positive by end of 2025

## Summary
- Raised $25.6M via convertible preferred stock at conversion prices of $0.73 and $0.83; majority from existing shareholders.
- Pro forma cash balance of $40.6M as of Q3 2024; aims to achieve operational cash flow positive run rate by end of 2025.
- Preferred stock pays 10% quarterly stock dividend for first four quarters; conversion subject to stockholder approval.
- Lock-up agreements with Series B & C preferred holders to receive up to 40% additional common shares over 12 months.

## SEC filing metadata
- accession: 0001104659-25-005237
- form_type: 8-K
- ticker: DRIO
- cik: 0001533998
- company_name: DarioHealth Corp.
- filed_at: 2025-01-22T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1533998/000110465925005237/0001104659-25-005237-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1533998/000110465925005237/tm254039d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-005237
- JSON: https://secwatch.observer/filing/0001104659-25-005237.json
- Plain text: https://secwatch.observer/filing/0001104659-25-005237.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.